cannabis; het endocannabinoide systeem en psychose drs. rebecca kuepper, maastricht university,...
TRANSCRIPT
![Page 1: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/1.jpg)
Cannabis; het endocannabinoide systeem en psychose
Drs. Rebecca Kuepper, Maastricht University,Psychiatry and Neuropsychology, The Netherlands
![Page 2: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/2.jpg)
StellingStelling
“Het gebruik van Cannabis is een
RISICO FACTOR voor schizofrenie !
![Page 3: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/3.jpg)
The dual images of Cannabis
![Page 4: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/4.jpg)
Murray et al, Nature Reviews Neuroscience, 2007
![Page 5: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/5.jpg)
Murray et al, Nature Reviews Neuroscience, 2007
![Page 6: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/6.jpg)
01020304050607080
% cannabis users
Patients Population
Cannabis and SchizophreniaCannabis and SchizophreniaCannabis and SchizophreniaCannabis and Schizophrenia
![Page 7: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/7.jpg)
• Hasj• Weed
• decreases:- negative symptoms (Compton, 2004;
Peralta and Cuesta, 1992)
- affective symptoms (Dixon, 1991)
• enhances: - positive affect - coping with negative affect - social functioning (Addington and Duchak,
1997; Spencer, 2002)
In Patients…..
![Page 8: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/8.jpg)
-1
0,5
2
3,5
Odd
s R
atio
's
0 < 1 permaand
3-4 permaand
1-2 perweek
> 3 perweek
Andreasson et al. Lancet, 1987
Association between frequency of cannabis use and later psychosis
15-year follow-up cohort study in N = 45.570
![Page 9: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/9.jpg)
Causaliteit ?Causaliteit ?
PSYCHOSISPSYCHOSIS
![Page 10: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/10.jpg)
Psychosis phenotypePsychosis phenotype
Psychotic Psychotic symptoms (5%)symptoms (5%)
Psychotic Psychotic experiences experiences
(15%)(15%)
Schizophrenia Schizophrenia (1%)(1%)
![Page 11: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/11.jpg)
Are subclinical symptoms a marker of genetic liability?
Are subclinical symptoms a marker of genetic liability?
1. Associated with risk factors for psychosis
2. Show continuity with illness
3. Cluster within families(twin studies)
![Page 12: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/12.jpg)
(RR=10)1st degree schizophrenic relative
Risk factors and effect in schizophrenia
RR 1 5 10
(Van Os et al 1998)
50% discordance
• prenatal exposure to influenza
• obstetric complications
• childhood trauma
• members of some immigrant populations
• urbanicity
• life events
• substance use
![Page 13: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/13.jpg)
Todo lo que ocurre en el cerebro es biología y todo lo que ocurre en la mente ocurre a través del cerebro.
Joseph le Doux, 1999
Todo lo que ocurre en el cerebro es biología y todo lo que ocurre en la mente ocurre a través del cerebro.
Joseph le Doux, 1999
MAOAMAOA
NOTCH4NOTCH4
SYN3SYN3
L1CAML1CAM
RELNRELN
G72/G30G72/G30
DAAODAAO
PRODHPRODH GRM3GRM3
DysbindinDysbindin
RGS4RGS4
NTRK1NTRK1BDNFBDNF
NRG1NRG1IL-1BIL-1B
DRD2DRD2COMTCOMT
SLC6A4SLC6A4
DRD3DRD3
DRD4DRD4
SLC6A3SLC6A3
HTR2AHTR2A
DISC1DISC1
Major gene?
Rare and inconsistent
![Page 14: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/14.jpg)
• zelf-medicatie?• symptomen of ziekte?• waarom niet iedereen?• waarom blijven patiënten gebruiken?
DEBAT
![Page 15: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/15.jpg)
EDSPEDSP (EEarly DDevelopmental SStages of PPsychopathology)
Prospective-longitudinal study on substance use and mental disorders
N = 3,021N = 3,021 (aged 14-24, birth cohorts 1970-1981)Follow-up at t1 (+2 years, only subsample)
t2t2 (+4 years, whole sample)t3t3 (+8 years, whole sample)
Substance use and clinical status were assessed using the CIDI (Composite International Diagnostic Interview)CIDI (Composite International Diagnostic Interview)
Lieb et al., 2000, Wittchen et al., 1998
CannabisCannabis & PsychosisPsychosis
![Page 16: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/16.jpg)
t0 t1
PsychPsych
PsychPsych
OR = 1.88, 95% CI: 1.11-3.17, OR = 1.88, 95% CI: 1.11-3.17, pp = 0.018 = 0.018
t3t2
Adjusted forAdjusted for age gender socio-economic status use of other drugs childhood trauma urbanicity
Kuepper et al., submitted
IsIs cannabiscannabis useuse associated with true true incidenceincidence of psychotic symptomspsychotic symptoms??
![Page 17: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/17.jpg)
t0 t1
PsychPsych
OR = 0.89, 95% CI: 0.67-1.19, OR = 0.89, 95% CI: 0.67-1.19, pp = 0.45 = 0.45
t3t2
Adjusted forAdjusted for age gender socio-economic status use of other drugs childhood trauma urbanicity
Kuepper et al., submitted
SELFMEDICATION?SELFMEDICATION?
![Page 18: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/18.jpg)
t0 t1
PsychPsych
t3t2
Kuepper et al., submitted
IsIs cannabiscannabis useuse associated with persistencepersistence of psychotic symptomspsychotic symptoms??
PsychPsych
![Page 19: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/19.jpg)
Kuepper et al., submitted
Is continued cannabis usecannabis use associated with greater risk of persistencepersistence of
psychotic symptomspsychotic symptoms??Risk of persistence* of psychotic
symptoms [OR (95%CI; p-value)]
Level of exposure unadjusted adjusted
no use 1 1
1.95 (1.22-3.11; 0.005) 1.63 (1.01-2.64; 0.045)
2.68 (1.53-4.72; 0.001) 2.21 (1.17-4.19; 0.015)
use at t1 or t2
use at t1 and t2*Persistence = psychotic symptoms at t2 AND at t3
![Page 20: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/20.jpg)
Is continued c cannabis useannabis use associated with greater risk of persistencepersistence of
psychotic symptomspsychotic symptoms??
![Page 21: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/21.jpg)
Cannabis effectsCannabis effects
+ No psychosis
???
![Page 22: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/22.jpg)
Age of first use:(Arseneault et al, 2002)
N=472 (12 – 23 jr)
Cann use before 14th
Cann use after 14th
CAPECommunity
Assessment of Psychic
Experiences
CAPECommunity
Assessment of Psychic
Experiences
The CAPE-42 is based on the PDI-21 and PDI-40 developed by Emmanuelle Peters et al (2001)
(van Os, Verdoux, Hanssen)
• Positive dimension psychosis
![Page 23: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/23.jpg)
Age of first use:
Onset before age 14 yrs
Onset after age 14 yrs
Ris
ik o
f p
sy
cho
tic
sy
mp
tom
s
Cannabis +Cannabis -
N=472 (12 – 23 jr)
Konings et al., Acta Psychiatr Scand, 2008.
![Page 24: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/24.jpg)
Cannabis
No sign of psychosis liability
Subclinical symptoms (SCL-
90)
Psychotic symptoms
Start:
4 years later:
EDSP;n=2436
THC * vulnerability interaction
![Page 25: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/25.jpg)
% psychotic symptoms
risk difference
No predisposition
Baseline predisposition
15%
21%6%
25%26%
51%
Henquet et al., BMJ 2006
-
+
+
-
THC * vulnerability interaction
Adjusted RD: 5.6% and 23.8% (for age, sex, SES, urbanicity, trauma, predisposition at follow-up)
![Page 26: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/26.jpg)
Genetische kwetsbaarheid ?Genetische kwetsbaarheid ?
• Dopamine: COMT-gene
Dopamine breakdown
psychosiscognition
COMT
• Endophenotype• D’Souza et al, 2005
Val
Val
Val
Met
Met
Met
Val158Met:
![Page 27: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/27.jpg)
Het dagelijks leven van patiHet dagelijks leven van patiëntenëntenHet dagelijks leven van patiHet dagelijks leven van patiëntenënten
Cannabis
Stemming
Hallucinaties
60 observaties:
PATRONEN VAN GEBRUIK EN SYMPTOMEN
![Page 28: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/28.jpg)
0
0,15
0,3
0,45
0,6
0,75
Eff
ect
Siz
e A
H
Met/MetVal/Met
Val/Val
COMT x Cannabis: ESM Hallucinations
‘hearing voices’ ‘seeing things’
Henquet et al., Neuropsychopharm, 2006.Henquet et al., Acta Psych Scan, 2009.
40 controls, 40 psychotic patients
![Page 29: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/29.jpg)
Gene-environment interplayGene-environment interplay
Psychosis
Henquet et al., Schizophrenia Bull, 2009.
![Page 30: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/30.jpg)
Beyond GEI…Beyond GEI…Beyond GEI…Beyond GEI…
Cannabis
No Childhoodtrauma
Childhoodtrauma
Psychotic symptoms (CAPE)
Assessed at age 7:
Assessed at age 19:
The Greek Birth Cohort study; N= 3500
Bakoula, Stefanis et al
![Page 31: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/31.jpg)
Beyond GEI…Beyond GEI…Beyond GEI…Beyond GEI…
0
0,2
0,4
0,6
0,8
1
1,2
1,4
No childhoodtrauma
Childhood trauma
No childhood trauma
Childhood trauma B= 0.20 (0.02-0.38),
p= 0.027
Eff
ect
Siz
e c
ann
ab
is o
n C
AP
E s
core
Konings et al., in preparationKonings et al., in preparation
B= 1.36 (0.67-1.59), p= 0.000
![Page 32: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/32.jpg)
Growing up in rural environment
Growing up in urban environment
Psychotic symptoms
T2:
T3:
EDSP studyEDSP study (age 14-24)EDSP studyEDSP study (age 14-24)
EDSP;(Wittchen,
LIeb, 1998)
n=2436
Cannabis
![Page 33: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/33.jpg)
Cannabis X urbanicity
% psychotic symptoms risk difference*
- 8% -1.0%95%CI: -0.7-0.05, p = 0.758
+ 6%
- 7%7.0%
95%CI: 0.01-0.12, p =0.019 + 15%
*Adjusted for age, gender, socio-economic status, use of other drugs, childhood trauma
rural
urban
Kuepper et al., submitted
![Page 34: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/34.jpg)
Cross-sensitization stress X THC
Kuepper et al., Schiz Res 2010
![Page 35: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/35.jpg)
• Hasj• Weed
9-tetrahydrocannabinol (THC)8-THC Cannabidiol (CBD) Cannabinol (CBN) Cannabigerol Cannabichromene
How THC might cause psychosis
(Mechoulam, 1960’s)
![Page 36: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/36.jpg)
Endocannabinoids act to modulate e.g. GABA and glutamate
![Page 37: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/37.jpg)
Neurobiology: THC and dopamine
• In rodents – THC facilitates DA transmission in several brain
regions including PFC and striatum (Chen et al., 1990; Jentsch et al., 1997, 1998; Tanda et al., 1997)
• In humans– THC might increase DA release in striatum
(Voruganti et al., 2001, Bossong et al., 2008)
biological pathway to psychosis?
![Page 38: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/38.jpg)
DA in schizophrenia
Mesocortical DA hypohypo-
activity
Mesolimbic DA hyperhyper-activity
DA D1 receptors
DA D2 receptors
Negative and cognitive symptoms
Positive and disorganized symptoms
Cognitive tasks Imaging
![Page 39: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/39.jpg)
Dopamine release can be inferred from displacement of IBZM or [18F]Fallypride
![Page 40: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/40.jpg)
![Page 41: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/41.jpg)
Rebecca Kuepper; Prof. Koen van Laere
![Page 42: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/42.jpg)
LR
Striatum
Baseline
Following THC
PET study
[18F]Fallypride
Baseline
![Page 43: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/43.jpg)
Burst firing of DA neurones in the ventral tegmental area (VTA) signifies the appearance of novel or salient stimuli.
Abnormal or dysregulated bursting in dopaminergic neurones may lead to the attachment of aberrant salience to otherwise mundane percepts and concepts and a delusional-style of thinking.
“…In this way, an unexpected sound, the comments of a TV news reader or eye contact with a stranger are transformed from trivial everyday occurrences into highly salient events of great personal meaning to the psychotic individual”.
Hyland, B. I.,(2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475-492
Kapur, S et al (2005) Schizophr Res 79, 59-68
Murray RM et al (2007) Nat. Rev Neurosci (2007).
Dopamine and Aberrant Salience
![Page 44: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/44.jpg)
01020304050607080
% cannabis users
Patients Population
Why do patients with schizophrenia use cannabis??
Why do patients with schizophrenia use cannabis??
![Page 45: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/45.jpg)
Acute effecten Acute effecten Acute effecten Acute effecten
geen THC
Ha
lluci
na
ties
na T
HC
Ste
mm
ing
geen THC
na THC
“Ik voel me opgewekt...”
“Ik hoor stemmen...”
Henquet et al., BJP 2010.
![Page 46: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/46.jpg)
Sub-acuut
Acuut
Effecten van Cannabis Effecten van Cannabis Effecten van Cannabis Effecten van Cannabis
“Ik voel me ontspannen...”
“Ik hoor stemmen...”
Henquet et al., BJP 2010.
![Page 47: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/47.jpg)
Patienten zijn verhoogd gevoelig Patienten zijn verhoogd gevoelig voor cannabisvoor cannabis
Patienten zijn verhoogd gevoelig Patienten zijn verhoogd gevoelig voor cannabisvoor cannabis
0
0,05
0,1
0,15
0,2
0,25
0,3
Eff
ec
t S
ize
(TH
C)
Stemming
Hallucinatio
ns
Controles
Patienten
![Page 49: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/49.jpg)
Minder angst / stress
Meer stemmen
Stress
Geautomatiseerde
overtuigingen
Als ik drink Ben ik meer relaxed word ik leuk gevondenAls ik cannabis gebruik Ben ik minder angstig Heb ik minder last van stemmen
![Page 50: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/50.jpg)
Behandeling:• Cognitieve gedrags therapie• Motiverende gespreksvoering• Terugvalpreventie
Gedurende 1 jaarVoor- en Nameting van symptomen en middelengebruik
X
Verwachtingen van gebruik
![Page 51: Cannabis; het endocannabinoide systeem en psychose Drs. Rebecca Kuepper, Maastricht University, Psychiatry and Neuropsychology, The Netherlands r.kuepper@sp.unimaas.nl](https://reader035.vdocument.in/reader035/viewer/2022081512/551b1ee35503462e578b61e1/html5/thumbnails/51.jpg)
Maastricht: Leuven:Dr. Cecile Henquet Prof.dr. Koen van LaereMonique Konings (GGzEindhoven)Maurice Smits (Mondriaan)Dr. Inez GermeysDr. Marinus van Kroonenburgh (azM)Prof.dr. Jim van Os
Grants:Zon-MW NWO (Veni-grant)